Each year on February 11th, the world celebrates the International Day of Women and Girls in Science. Established by the United Nations a decade ago, this observance highlights women’s vital contributions to science and technology while pushing for greater inclusion in STEM fields (Science, Technology, Engineering, and Mathematics).

Addressing the Gender Gap

Despite significant progress, the gender gap in scientific research remains stark. According to UN statistics, women comprise just one-third (33.3%) of researchers worldwide, with their representation dropping even lower in emerging fields like artificial intelligence, where they account for only 22% of researchers. These numbers reflect persistent challenges, including ingrained cultural stereotypes, a shortage of female role models, and inequitable research funding distribution.

The significance of this day extends beyond mere recognition. Research consistently shows that diverse teams produce more innovative solutions and achieve better scientific outcomes. As the UN emphasizes, women and girls are key drivers of change, playing a crucial role in reaching the 2030 Sustainable Development Goals.

Menarini Biotech’s innovation and Meri Gabrielli’s leadership journey 

One company exemplifying the power of inclusive scientific leadership is Menarini Biotech. This Italian biotechnology firm has built its reputation on developing biologics, specifically recombinant proteins and antibodies for clinical, pre-clinical, and commercial use. What began as an internal development arm of the Menarini Group has grown over 25 years into a trusted contract development and manufacturing organization (CDMO) delivering cutting-edge solutions to the pharmaceutical industry.

Based near Rome, Menarini Biotech’s advanced Pomezia facility offers comprehensive services to pharmaceutical and biotech companies. As the only facility of its kind in Italy, the site’s capabilities span drug development, manufacturing, and analytical support, with state-of-the-art equipment including 1,000-liter single-use bioreactors for large-scale mammalian cell production.

The company has made significant strides in cancer research, investing years in developing anticancer antibodies. Their collaboration with Oxford BioTherapeutics (OBT) on antibody-drug conjugates (ADCs) represents a breakthrough in oncology treatment. The company’s expertise was further demonstrated during the pandemic when they developed a monoclonal antibody targeting COVID-19 in just four months, taking it from research through to production.

Meri Gabrielli, Head of Technology Development at Menarini Biotech, embodies the company’s commitment to scientific excellence. After completing her PhD in protein chemistry in collaboration with Menarini, she joined the company in 1998. Starting in analytical quality control, she worked her way up to leading strategic process development. Today, she oversees the entire development process, from cell line development through product characterization to industrial scale-up. “We strive to provide patients with groundbreaking treatments as quickly as possible, using advanced technology and top-tier expertise”, Gabrielli explains.

“At Menarini, everyone’s voice matters, and we’ve built a culture that genuinely supports work-life balance.” This commitment shows in the numbers: women represent 60% of the staff and play key roles in advancing the company’s mission.

Looking back on her career, Gabrielli credits her success to an unwavering enthusiasm for science discovery. “Research continues to fascinate me every day”, she reflects. “When you’re passionate about your work, challenges become growth opportunities. I believe following our passion is the key to tackling even the most complex problems.”

Check out Menarini Biotech online – visit the website and connect on LinkedIn!

Building a more equitable future 

The International Day of Women and Girls in Science serves as both a celebration and a catalyst for change. As Gabrielli notes, “At Menarini, we’re not just developing breakthrough treatments – we’re advancing our mission to improve patients’ lives, and our diverse, passionate team makes that possible.”

Women and girls bring unique perspectives that can revolutionize scientific discoveries. By creating an environment where they can thrive, we’re building a path toward a future where their talent can truly shine through.